Isolation and Characterization of Engineered Nucleoside Deoxyribosyltransferase with Enhanced Activity Toward 2’-Fluoro-2’- Deoxynucleoside
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Nucleoside deoxyribosyltransferase (NDT) is an enzyme that replaces the purine or pyrimidine base of 2′-deoxyribonucleoside. This enzyme is generally used in the nucleotide salvage pathway in vivo and synthesizes many nucleoside analogs in vitro for various biotechnological purposes. Since NDT is known to exhibit relatively low reactivity toward nucleoside analogs such as 2’-fluoro-2’- deoxynucleoside, it is necessary to develop an enhanced NDT mutant enzyme suitable for nucleoside analogs. In this study, molecular evolution strategy via error-prone PCR was performed with ndt gene derived from Lactobacillus leichmannii as a template to obtain an engineered NDT with higher substrate specificity to 2FDU (2′-fluoro-2′-deoxyuridine). A mutant library of 214 ndt genes with different sequences was obtained and performed for the conversion of 2FDU to 2FDA (2′-fluoro- 2′-deoxyadenosine). The E. coli containing a mutant NDT, named NDTL59Q, showed 1.7-fold (at 40°C) and 4.4-fold (at 50°C) higher 2FDU-to-2FDA conversions compared to the NDTWT, respectively. Subsequently, both NDTWT and NDTL59Q enzymes were over-expressed and purified using a His-tag system in E. coli. Characterization and enzyme kinetics revealed that the NDTL59Q mutant enzyme containing a single point mutation of leucine to glutamine at the 59th position exhibited superior thermal stability with enhanced substrate specificity to 2FDU.
Abstract
Nucleoside deoxyribosyltransferase (NDT) is an enzyme that replaces the purine or pyrimidine base of 2′-deoxyribonucleoside. This enzyme is generally used in the nucleotide salvage pathway in vivo and synthesizes many nucleoside analogs in vitro for various biotechnological purposes. Since NDT is known to exhibit relatively low reactivity toward nucleoside analogs such as 2’-fluoro-2’- deoxynucleoside, it is necessary to develop an enhanced NDT mutant enzyme suitable for nucleoside analogs. In this study, molecular evolution strategy via error-prone PCR was performed with ndt gene derived from Lactobacillus leichmannii as a template to obtain an engineered NDT with higher substrate specificity to 2FDU (2′-fluoro-2′-deoxyuridine). A mutant library of 214 ndt genes with different sequences was obtained and performed for the conversion of 2FDU to 2FDA (2′-fluoro- 2′-deoxyadenosine). The E. coli containing a mutant NDT, named NDTL59Q, showed 1.7-fold (at 40°C) and 4.4-fold (at 50°C) higher 2FDU-to-2FDA conversions compared to the NDTWT, respectively. Subsequently, both NDTWT and NDTL59Q enzymes were over-expressed and purified using a His-tag system in E. coli. Characterization and enzyme kinetics revealed that the NDTL59Q mutant enzyme containing a single point mutation of leucine to glutamine at the 59th position exhibited superior thermal stability with enhanced substrate specificity to 2FDU.
참고문헌 (17)
- Crooke ST, "Antisense technology : an overview and prospectus", Nat. Rev. Drug. Discov, 20, pp.427~453 (2021)
- Chan JHP, "Antisense oligonucleotides : from design to therapeutic application", Clin. Exp. Pharmacol. Physiol, 33, pp.533~540 (2006)
- Dhuri K, "Antisense oligonucleotides : an emerging area in drug discovery and development", J. Clin. Med, 9, pp.2004~ (2020)
- Ochoa S, "Modified nucleic acids : expanding the capabilities of functional oligonucleotides", Molecules, 25, pp.4659~ (2020)
- McKenzie LK, "Recent progress in non-native nucleic acid modifications", Chem. Soc. Rev, 50, pp.5126~5164 (2021)
- Xiong H, "Recent advances in oligonucleotide therapeutics in oncology", Int. J. Mol. Sci, 22, pp.3295~ (2021)
- C. J. Wilds, "2'-Deoxy-2'-fluoro-beta-D-arabinonucleosides and oligonucleotides (2'F-ANA): synthesis and physicochemical studies", Nucleic Acids Research, 28(18), pp.3625~3635 (2000), Oxford University Press (OUP)[DOI]
- Manoharan M, "2′-Carbohydrate modifications in antisense oligonucleotide therapy : importance of conformation, configuration and conjugation", Biochim. Biophys. Acta, 1489, pp.117~130 (1999)
- Munch-Petersen, "Metabolism of nucleotides, nucleosides and nucleobases in microorganisms", Academic Press Inc, pp.203~258 (1983)
- Roush AH, "Purification and properties of trans-N-deoxyribosylase", J. Biol. Chem, 233, pp.261~266 (1958)
- R. Cardinaud, "Nucleoside deoxyribosyltransferase-II from Lactobacillus helveticus. Substrate specificity studies. Pyrimidine bases as acceptors", Biochimica et Biophysica Acta (BBA) - Enzymology, 568(2), pp.339~347 (1979), Elsevier BV[DOI]
- Charles DANZIN, "Deoxyribosyl Transfer Catalysis with trans-N-Deoxyribosylase. Kinetic Studies of Purine-to-Purine trans-N-Deoxyribosylase", European Journal of Biochemistry, 48(1), pp.255~262 (1974), Wiley[DOI]
- Charles DANZIN, "Deoxyribosyl Transfer Catalysis with trans-N-Deoxyribosylase. Kinetic Studies of Purine-to-Purine trans-N-Deoxyribosylase", European Journal of Biochemistry, 48(1), pp.255~262 (1974), Wiley[DOI]
- Lysik MA, "Innovations in oligonucleotide drug delivery", J. Pharm. Sci, 92, pp.1559~1573 (2003)
- Liu P, "Fluorinated nucleosides : synthesis and biological implication", J. Fluor. Chem, 129, pp.743~766 (2008)
- David S. Wilson, "Random Mutagenesis by PCR", Current Protocols in Molecular Biology (2001), John Wiley & Sons, Inc.[DOI]
- Cadwell RC, "Randomization of genes by PCR mutagenesis", PCR Methods Appl, 2, pp.28~33 (1992)